Keywords
Transurethral plasma enucleation
Safety
Effectiveness
Submitted : 2023-10-15
Accepted : 2023-10-30
Published : 2023-11-14
Abstract
Objective: This paper aims to analyze the effectiveness and safety of transurethral plasma enucleation in clinical treatment of benign prostatic hyperplasia. Methods: A total of 100 patients with benign prostatic hyperplasia who received surgical treatment in our hospital from January 2022 to January 2023 were randomly divided into groups by envelope method. 50 patients who received transurethral plasma resection of the prostate were selected as the control group and 50 patients who received transurethral plasma enucleation of the prostate were the study group. The effective rate of treatment, incidence of complications, postvoid residual (PVR) volume, maximum urinary flow rate (Qmax), and international prostate symptom score (I-PSS) were compared between the two groups. Results: By comparison, the effective rate of treatment in the study group was higher (P < 0.05). By comparison, the incidence of complications in the study group was lower (P < 0.05). Before treatment, there was no significant difference in PVR, Qmax, and I-PSS scores between the two groups (P > 0.05). After treatment, the PVR and I-PSS scores of the study group were lower, and Qmax was higher (P < 0.05). Conclusion: In the treatment of benign prostatic hyperplasia, the application of transurethral plasma enucleation can improve the clinical efficacy and clinical symptoms, with high safety and application value.
References
Zhao H, 2023, Analysis of the Effect of Transurethral Bipolar Plasma Enucleation of the Prostate in the Treatment of Benign Prostatic Hyperplasia. Henan Journal of Surgery, 29(3): 142–144.
Zhong H, Zhao F, Wu G, 2022, Efficacy and Safety Analysis of Transurethral Plasma Enucleation of the Prostate in the Treatment of Benign Prostatic Hyperplasia. Chinese Science and Technology Journal Database (Citation Edition) Medicine and Health, 2022(1): 8–10.
Han Y, Li Y, Bai Y, et al., 2021, Comparison of the Effect of Transurethral Plasma Enucleation of the Prostate and Transurethral Resection in the Treatment of Benign Prostatic Hyperplasia. Contemporary Medical Forum, 19(14): 71–73.
Urology Professional Committee of Chinese Research Hospital Association, Evidence-Based Medicine Branch of China Healthcare International Exchange Promotion Association, 2018, Guidelines for the Treatment of Benign Prostatic Hyperplasia in China (2018 Simplified Version). Modern Journal of Urology, 2018(9): 651–654.
Zhong X, Li X, 2020, Meta-Analysis of Transurethral Holmium Laser Enucleation and Transurethral Plasma Enucleation in the Treatment of Benign Prostatic Hyperplasia. Modern Medicine, 48(9): 1143–1149.
Zhu X, Li J, Yu Z, et al., 2022, A Comparative Study on the Clinical Efficacy of Transurethral Plasma Enucleation of the Prostate and Transurethral Resection of the Prostate in the Treatment of Benign Prostatic Hyperplasia. Advances in Modern Biomedicine, 22(12): 2280–2283 + 2288.
Ding H, Chen S, Jiang Q, 2022, Comparison of Short-Term Prognosis of Patients with Benign Prostatic Hyperplasia after Holmium Laser and Plasma Enucleation of the Prostate. Chinese Medicine, 17(2): 236–240.
Cai X, Mao M, Li X, et al., 2019, Comparative Analysis of the Efficacy and Safety of TUPKEP and TURP in the Treatment of Benign Prostatic Hyperplasia. Chinese Sexology, 28(3): 32–35.
Xiao H, Wu J, Feng J, 2020, Clinical Comparative Study of Transurethral Holmium Laser Enucleation of the Prostate and Transurethral Plasma Resection of the Prostate in the Treatment of Benign Prostatic Hyperplasia. Chinese Sexology, 29(1): 34–37.
Mou X, Xie H, Li Q, 2019, Exploring the Application Value of Transurethral Plasma Enucleation of the Prostate in the Treatment of Benign Prostatic Hyperplasia. Chinese Sexology, 28(3): 18–21.
Wei H, 2023, Comparative Analysis of Clinical Efficacy of Transurethral Bipolar Plasma Enucleation of the Prostate (TUPEP) and Transurethral Resection of the Prostate (TURP) in the Treatment of Benign Prostatic Hyperplasia. Chinese Science and Technology Journal Database (Citation Edition). Medicine and Health, 2023(4): 66–69.
Niu X, 2022, Discussion on the Clinical Effectiveness and Safety of Transurethral Plasma Enucleation in the Treatment of Benign Prostatic Hyperplasia. Systematic Medicine, 7(17): 130–133.
Hong Y, Li W, Liu Z, et al., 2023, The Clinical Value of Transurethral Plasma Enucleation of the Prostate in the Treatment of Benign Prostatic Hyperplasia. Chinese Medicine Innovation, 20(1): 64–67.